The restructuring includes the elimination of certain roles and a reduction in the company’s global real estate footprint.

The extended review for Elinzanetant is supported by data from the Phase III OASIS 1, 2, and 3 trials, which supported the ...

Hengrui Pharma partners with GSK to develop 12 innovative medicines, enhancing COPD treatment and expanding global growth ...

PE: Where has AI been successfully implemented already? Li: We’re current working with three of the top 10 pharmaceutical ...

John Showalter, MD, MSIS, chief operating officer at Linus Health, added, “We've built our platform to be embedded ...

Under terms of the deal, Bavarian Nordic shareholders will receive an all-cash offer at a premium, with plans to delist the ...

AI influencers represent the cutting edge of digital storytelling. But when applied to pharmaceutical marketing, innovation must be balanced with integrity.

Boehringer Ingelheim partners with Re-Vana Therapeutics to innovate long-acting eye disease treatments, enhancing patient care and compliance.

Despite surging GenAI adoption in pharma and the FDA’s recent embrace of the technology, a trust gap remains with GenAI implementations. The story describes four essentials that improve trust in GenAI ...

The regulatory actions were based on results from the Phase III MATTERHORN trial (NCT04592913), which showed that a ...

A special segment of “Empowered with Meg Ryan” featuring a collaboration with Kings View will air for public television users ...

The latest announcement comes from Simtra BioPharma Solutions, a global CDMO, with US headquarters located in Parsippany, NJ.